Acumen Pharmaceuticals (ABOS) Other Working Capital Changes (2022 - 2024)
Acumen Pharmaceuticals (ABOS) reported Other Working Capital Changes of -$30000.0 for Q3 2024, down 11.11% on a YoY basis from -$33750.0 in Q4 2023, and down 3.45% sequentially from -$29000.0 in Q2 2024.
Acumen Pharmaceuticals (ABOS) Other Working Capital Changes (2022 - 2024) Analysis & Trends
Acumen Pharmaceuticals (ABOS) has 3 years of Other Working Capital Changes data on file, last reported at -$30000.0 in Q3 2024.
- For the quarter ending Q3 2024, Other Working Capital Changes fell 11.11% year-over-year to -$30000.0; the trailing twelve-month figure through Sep 2024 stood at -$87000.0 (up 37.86% YoY), and the FY2023 full-year result was -$110000.0, up 19.71% from the prior year.
- Other Working Capital Changes declined to -$30000.0 in Q3 2024, from -$29000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.4 million in Q2 2024 to a low of -$2.2 million in Q3 2022.
- A 5-year average of -$1588.2 and a median of -$35000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 81.08% in 2023, while the deepest fall reached 18.75% in 2023.
- Tracing ABOS's Other Working Capital Changes over 3 years: stood at -$37000.0 in 2022, then soared by 81.08% to -$7000.0 in 2023, then plunged by 328.57% to -$30000.0 in 2024.
- Business Quant data shows ABOS's Other Working Capital Changes at -$30000.0 in Q3 2024, -$29000.0 in Q2 2024, and -$21000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn |
| 10 | Acumen Pharmaceuticals | 140.66 Mn | 140.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Jun 30, 2023 | -38,000.00 |
| Jun 30, 2023 | -38,000.00 |
| Jun 30, 2023 | -38,000.00 |
| Mar 31, 2023 | -38,000.00 |
| Mar 31, 2023 | -38,000.00 |